Study of V117957 in Overactive Bladder Syndrome

NCT06024642 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder Syndrome

Interventions

DRUG: V117957
DRUG: Placebo

Sponsor

Imbrium Therapeutics

Collaborators

[object Object]